Navigation Links
CVS Caremark Emphasizes Commitment to Older Americans at Annual American Society on Aging Conference
Date:3/12/2013

WOONSOCKET, R.I., March 12, 2013 /PRNewswire/ -- CVS Caremark (NYSE: CVS) will highlight how medication adherence plays a vital role in helping older Americans on their path to better health at the 2013 Annual American Society on Aging Conference, which is being held in Chicago this week.

(Logo:  http://photos.prnewswire.com/prnh/20090226/NE75914LOGO )

CVS Caremark, a Titanium Sponsor of the conference, will also be participating in a number of general sessions and panels and will highlight its efforts to ensure customers and patients receive quality care and guidance as they age. David Casey , the company's Vice President of Workforce Strategies and Chief Diversity Officer, will open the March 12 General Session: Mysteries of Population Aging

As a pharmacy innovation company, CVS Caremark is committed to developing new ways to lower costs and improve health. By advancing the understanding of medication adherence through research collaborations, the company is gathering important information about why some patients take their medications as prescribed and why others do not. CVS Caremark is also refining the ways it interacts with patients through proven programs, such as Pharmacy Advisor and Maintenance Choice, that help patients stay on their medications and improve health outcomes.

"People age 65 and older typically take two or three times as many medications as younger Americans," said Casey. "As we reinvent pharmacy care, we will continue to be a trusted health care partner to all of our customers, but particularly to aging Americans who are more likely to have chronic conditions and require more guidance."        

CVS Caremark
'/>"/>

SOURCE CVS Caremark
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
2. CVS Caremark Reports Record First Quarter Results
3. CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate Negative Impact on Medication Adherence, Even if Not Related to Safety
4. CVS Caremark Research Identifies Positive Link Between Medication Adherence and Employee Productivity
5. CVS Caremark Charitable Trust Partners with National Association of Community Health Centers to Create Innovative Grant Program Focused on Managing Chronic Disease
6. CVS Caremark To Present At Goldman Sachs 2012 Global Retailing Conference
7. CVS Caremark to Present at Morgan Stanley Global Healthcare Conference
8. CVS Caremark Corporation Announces New Share Repurchase Authorization for up to $6 Billion of Common Stock
9. CVS Caremark Donates More Than $100,000 to Hurricane Sandy Relief Efforts
10. CVS Caremark To Present At Lazard Capital Markets 9th Annual Healthcare Conference
11. CVS Caremark Reports Third Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 20, 2015 ... addition of the "Global Post-traumatic Stress Disorder Therapeutics ... The global PTSD therapeutics market to grow at a ... This report covers the present scenario and the growth ... period 2015-2019. To calculate the market size, the report ...
(Date:7/28/2015)... July 28, 2015 According to a ... Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, ... - Forecast to 2020", published by MarketsandMarkets, the European Injectable ... 2020 from $114.7 Billion in 2015, growing at a CAGR ... 230 market data T ables ...
(Date:7/27/2015)... SEATTLE , July 28, 2015 CTI ... it plans to report its second quarter 2015 financial ... of the U.S. financial markets. Following the announcement, members ... call to discuss the results and provide a general ... Access to the event can be obtained as follows: ...
Breaking Medicine Technology:Global Post-traumatic Stress Disorder Therapeutics Market 2015-2019 - Growing Number of Accidents and Violence Worldwide Drives the Market 2European Injectable Drug Delivery Market Worth $207.3 Billion by 2020 2European Injectable Drug Delivery Market Worth $207.3 Billion by 2020 3European Injectable Drug Delivery Market Worth $207.3 Billion by 2020 4CTI BioPharma to Report Second Quarter 2015 Financial Results on August 6, 2015 2
... Model of Diabetes with Haptoglobin 2-2 Genotype Show, ... Transport, MONTVALE, N.J., March 31 Synvista,Therapeutics, ... a study of diabetic mice,with the Haptoglobin 2-2 ... Haptoglobin (Hp)-Hemoglobin (Hb) complex may result in a ...
... is now enrolling ... patients, ... announced today the start of a Phase III clinical trial,studying LY450139, an ... LY450139 is being tested,to see if it can slow the progression associated ...
Cached Medicine Technology:Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions 2Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions 3Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions 4Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease 2Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease 3Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease 4Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease 5Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease 6
(Date:7/28/2015)... ... July 28, 2015 , ... ADLINK Technology, a ... edge devices that enable the Internet of Things (IoT), announced its new medical ... to provide exceptional computing power and multitasking capabilities. The MLC 4-21 is completely ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... much-anticipated U.S. commercial launch of its ORTHALIGN PLUS® system, a palm-sized, single-use navigation ... , “OrthAlign successfully combined precision with practicality in a revolutionary way for ...
(Date:7/28/2015)... ... July 28, 2015 , ... On July 16th NPR ... schedule the hearing of proposed bills and laws revolving the implementation of a small ... date. Some vigilante ministers are continuing to hand out clean needles to drug users ...
(Date:7/28/2015)... ... 2015 , ... BiologicsMD, Inc. , a privately held ... of bone disorders and conditions of hair loss, announced that the U.S. Patent ... Binding-Domain and Parathyroid Hormone". The issued patent claims methods of use for promoting ...
(Date:7/28/2015)... ... July 28, 2015 , ... Fertility specialist Dr. Lisa Hasty ... 2015” by Atlanta Magazine. In Atlanta Magazine's annual Top Doctors issue, Dr. Hasty has ... colleagues and peers in the metro area as one of the most respected doctors ...
Breaking Medicine News(10 mins):Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 2Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 3Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 2Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 3Health News:Needle Exchange Programs Are Delayed in Legislation, West Palm Beach Drug Rehab Comments 2Health News:Needle Exchange Programs Are Delayed in Legislation, West Palm Beach Drug Rehab Comments 3Health News:BiologicsMD, Inc. Announces Additional US Patent Issuance Covering Company’s Pipeline of Targeted Therapies 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3
... has revealed how change in body temperature impacts the ... Conti of the Scripps Research Institute in La Jolla, ... to prolong life and found that the lifespan of ... core body temperature, reported the health portal News Medical., ...
... meeting on breathing disorders in Paris discussed the ongoing research ... need to revamp the more than a century old test ... which the strains of TB have become resistant. ... the 37th world congress of the Union for breathing health ...
... restaurants to list the calories of all items offered in ... already offered the information regarding calories of various items offered by ... the back of tray liners and in restaurant brochures. ... are resisting the idea. It is a change to be welcomed ...
... Yoga is a path to optimal health by achieving a healthy ... undertaken by many for over 5,000 years//. ,The November ... and its health benefits. ,Yoga has its roots in ... of relaxation, postures and breathing. Several forms of yoga have evolved ...
... 100 health professionals put their heads together to thrash ... is weakening the healthcare system in Queensland. The// representatives ... nuclear medicine technologists in state-run hospitals has warned that ... staff, in the absence of any action. ...
... primary health care for patients that was released by ... developed// countries, except the U.S. ,In the ... it was found that Canada lagged in several aspects ... records, doctors availability after hours, multi-discipline teams for treatment ...
Cached Medicine News:
... assays are designed for ... 2000, a high-throughput, continuous ... IMMULITE 2000 offers testing ... a rapidly expanding menu ...
... from KUBTEC is a dual capability system with ... representation of the specimen under test. While the ... images, the micro focus source also allows the ... standard 2D images. The 100 mm x 100 ...
... specimen radiography. The XPERT represents a research tool ... gray in every digital x-ray image, thus being ... that heretofore were lost to the human eye. ... 2 to 8 x 8 in size, multi-color ...
The Triage Profiler Shortness of Breath Panel provides rapid risk assessment and differential diagnosis of patients presenting to the emergency department with shortness of breath and risk assessment...
Medicine Products: